Show simple item record

Tamizaje de reserva ovárica con hormona antimülleriana

dc.contributor.authorReyes-Armas, I.
dc.contributor.authorÑiquena, F.C.
dc.date.accessioned2025-10-31T18:40:19Z
dc.date.available2025-10-31T18:40:19Z
dc.date.issued2018
dc.identifier.urihttp://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2304-51322018000300004
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5806
dc.description.abstractCurrently, ovarian reserve (OR) tests are mainly used in the evaluation of subfertile patients. In this paper, we discuss the use of anti-Müllerian hormone (AMH) levels, which have been associated in some cases with antral follicle count (AFC) and FSH levels in young women, and we propose an algorithm to identify the risk of reduced ovarian reserve. Using her full autonomy and after counseling, the woman would decide whether or not to do the tests, according to her priorities in life. If these tests were altered, the woman could modify her plans in regard to motherhood.en_US
dc.formatapplication/pdf
dc.language.isospa
dc.publisherPeruvian Society of Obstetrics and Gynecology
dc.relation.ispartofurn:issn:2304-5124
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectTesticular and Splenic Tumorsen_US
dc.subjectAnti-Müllerian Hormone and Ovarian Reserve Insightsen_US
dc.titleTamizaje de reserva ovárica con hormona antimüllerianaes_PE
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.02
dc.type.otherResearch article
dc.identifier.journalRevista Peruana de Ginecologia y Obstetricia
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2